Seres Therapeutics, Inc. Annual Return On Assets in % from 2016 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Seres Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2024.
  • Seres Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2025 was 54.9 %.
  • Seres Therapeutics, Inc. annual Return On Assets for 2024 was 0.06 %.
  • Seres Therapeutics, Inc. annual Return On Assets for 2023 was -32.4 %, a 59.4% increase from 2022.
  • Seres Therapeutics, Inc. annual Return On Assets for 2022 was -79.8 %, a 304% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 0.06 +32.5 Jan 1, 2024 Dec 31, 2024
2023 -32.4 +47.4 +59.4% Jan 1, 2023 Dec 31, 2023
2022 -79.8 -60 -304% Jan 1, 2022 Dec 31, 2022
2021 -19.8 +19.4 +49.5% Jan 1, 2021 Dec 31, 2021
2020 -39.2 +16 +29% Jan 1, 2020 Dec 31, 2020
2019 -55.2 +20.7 +27.3% Jan 1, 2019 Dec 31, 2019
2018 -75.8 -34.4 -82.9% Jan 1, 2018 Dec 31, 2018
2017 -41.5 -10.9 -35.9% Jan 1, 2017 Dec 31, 2017
2016 -30.5 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.